Differential regulation of matrix metalloproteinase-9 and tissue plasminogen activator activity by the Cyclic-AMP system in lipopolysaccharide-stimulated rat primary astrocytes

被引:31
作者
Lee, Soon Young [2 ,3 ]
Kim, Hee Jin [4 ]
Lee, Woo Jong [1 ]
Joo, So Hyun [2 ,3 ]
Jeon, Se-Jin [1 ]
Kim, Ji Woon [2 ,3 ]
Kim, Hee Sun [2 ,3 ]
Han, Seol-Heui [2 ,3 ]
Lee, Jongmin [2 ,3 ]
Park, Seung Hwa [3 ,5 ]
Cheong, Jae Hoon [4 ]
Kim, Won-Ki [6 ]
Ko, Kwang Ho [1 ]
Shin, Chan Young [2 ,3 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Dept Pharmacol, Seoul, South Korea
[2] Konkuk Univ, Sch Med, Dept Pharmacol, Seoul 143701, South Korea
[3] Konkuk Univ, Ctr Geriatr Neurosci Res, Inst Biomed Sci & Technol, Seoul 143701, South Korea
[4] Samyook Univ, Sch Pharm, Dept Pharmacol, Seoul, South Korea
[5] Konkuk Univ, Sch Med, Dept Anat, Seoul, South Korea
[6] Korea Univ, Coll Med, Dept Neurosci, Seoul 136705, South Korea
关键词
zymography; PAI-1; post-transcriptional control; promoter activity; RT-PCR; isoproterenol;
D O I
10.1007/s11064-008-9737-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
We investigated the effect of the cAMP system on lipopolysaccharide (LPS)-induced changes in the activity of matrix metalloproteinases (MMPs) and tissue plasminogen activator (tPA) in rat primary astrocytes. LPS stimulation increased MMP-9 and decreased tPA activity in rat primary astrocytes. Co-treatment with a cAMP analog, dibutyryl-cAMP (db-cAMP), or the cAMP elevating beta-adrenergic agonist, isoproterenol, concentration-dependently inhibited LPS-induced MMP-9 activity. In contrast, db-cAMP concentration-dependently increased tPA activity in both basal and LPS-stimulated rat primary astrocytes. To confirm the effect of cAMP on MMP-9 and tPA activity, we treated LPS-stimulated astrocytes with cAMP phosphodiesterase inhibitors, IBMX or rolipram, and they exhibited similar effects to db-cAMP, namely decreasing MMP-9 activity and increasing tPA activity. RT-PCR analysis of MMP-9 mRNA expression and MMP-9 promoter luciferase reporter assays revealed transcriptional upregulation by LPS stimulation and downregulation by db-cAMP. In contrast, the level of tPA mRNA expression was increased both by LPS and by cAMP treatment. Consistent with RT-PCR analysis, tPA promoter reporter assays showed increased activity by both LPS and cAMP stimulation. Interestingly, the level of mRNA encoding plasminogen activator inhibitor-1 (PAI-1) was increased by LPS stimulation and decreased back to control level after co-treatment with db-cAMP, suggesting that PAI-1 expression plays a major role in the regulation of tPA activity. To examine PKA involvement in the effects of db-cAMP on MMP-9 and tPA activity, we added the PKA inhibitors, H89 or rp-cAMP, along with db-cAMP, and they inhibited db-cAMP-mediated changes in tPA activity without affecting MMP-9 activity. These data suggest that cAMP differentially modulates MMP-9 and tPA activity through a mechanism related to PKA activation. The differential regulation of MMP-9 and tPA by the cAMP system may confer more sophisticated regulation of physiological processes, such as extracellular matrix remodeling and cell migration, by activated astrocytes.
引用
收藏
页码:2324 / 2334
页数:11
相关论文
共 64 条
[1]
Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease [J].
Adair, JC ;
Charlie, J ;
Dencoff, JE ;
Kaye, JA ;
Quinn, JF ;
Camicioli, RM ;
Stetler-Stevenson, WG ;
Rosenberg, GA .
STROKE, 2004, 35 (06) :E159-E162
[2]
Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS [J].
Anthony, DC ;
Miller, KM ;
Fearn, S ;
Townsend, MJ ;
Opdenakker, G ;
Wells, GMA ;
Clements, JM ;
Chandler, S ;
Gearing, AJH ;
Perry, VH .
JOURNAL OF NEUROIMMUNOLOGY, 1998, 87 (1-2) :62-72
[3]
Essential role for ERK mitogen-activated protein kinase in matrix metalloproteinase-9 regulation in rat cortical astrocytes [J].
Arai, K ;
Lee, SR ;
Lo, EH .
GLIA, 2003, 43 (03) :254-264
[4]
Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia [J].
Asahi, M ;
Wang, XY ;
Mori, T ;
Sumii, T ;
Jung, JC ;
Moskowitz, MA ;
Fini, ME ;
Lo, EH .
JOURNAL OF NEUROSCIENCE, 2001, 21 (19) :7724-7732
[5]
Asahina M, 2001, CLIN NEUROPATHOL, V20, P60
[6]
Backstrom JR, 1996, J NEUROSCI, V16, P7910
[7]
Role of TLR4 polymorphisms in inflammatory responses -: Implications for unsuccessful aging [J].
Balistreri, Carmela Rita ;
Candore, Giuseppina ;
Listi, Florinda ;
Fazio, Teresa ;
Gangi, Simona ;
Incalcaterra, Egle ;
Caruso, Marco ;
Li Vecchi, Maurizio ;
Lio, Domenico ;
Caruso, Calogero .
MOLECULAR MECHANISMS AND MODELS OF AGING, 2007, 1119 :203-207
[8]
Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes [J].
Bator, JM ;
Cohen, RL ;
Chambers, DA .
EXPERIMENTAL CELL RESEARCH, 1998, 242 (01) :110-119
[9]
Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms [J].
Cacquevel, Mathias ;
Launay, Severine ;
Castel, Herve ;
Benchenane, Karim ;
Cheenne, Simon ;
Buee, Luc ;
Moons, Lieve ;
Delacourte, Andre ;
Carmeliet, Peter ;
Vivien, Denis .
NEUROBIOLOGY OF DISEASE, 2007, 27 (02) :164-173
[10]
Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation [J].
Carmeliet, P ;
Moons, L ;
Lijnen, HR ;
Baes, M ;
Lemaitre, V ;
Tipping, P ;
Drew, A ;
Eeckhout, Y ;
Shapiro, S ;
Lupu, F ;
Collen, D .
NATURE GENETICS, 1997, 17 (04) :439-444